These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7839081)

  • 21. The effects of topical agents of fluticasone propionate, oxymetazoline, and 3% and 0.9% sodium chloride solutions on mucociliary clearance in the therapy of acute bacterial rhinosinusitis in vivo.
    Inanli S; Oztürk O; Korkmaz M; Tutkun A; Batman C
    Laryngoscope; 2002 Feb; 112(2):320-5. PubMed ID: 11889391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study.
    Tas A; Yagiz R; Yalcin O; Uzun C; Huseyinova G; Adali MK; Karasalihoglu AR
    Otolaryngol Head Neck Surg; 2005 Apr; 132(4):608-12. PubMed ID: 15806055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways.
    Svensson C; Pipkorn U; Alkner U; Baumgarten CR; Persson CG
    Clin Exp Allergy; 1992 Mar; 22(3):411-6. PubMed ID: 1586878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine.
    Borum S; Nielsen K; Bisgaard H; Mygind N
    Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of vasoconstrictor pre-treatment on obstruction, secretion and sneezing after nasal challenge with threshold and suprathreshold allergen doses.
    Brooks CD; Karl KJ; Francom SF
    Rhinology; 1993 Dec; 31(4):165-8. PubMed ID: 8140382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of nasal histamine and allergen provocations in patients with allergic rhinitis].
    Tahamiler R; Saritzali G; Canakçioğlu S
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):30-6. PubMed ID: 17483609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Airway reactivity and exhaled NO following swine dust exposure in healthy volunteers.
    Kölbeck KG; Ehnhage A; Juto JE; Forsberg S; Gyllenhammar H; Palmberg L; Larsson K
    Respir Med; 2000 Nov; 94(11):1065-72. PubMed ID: 11127493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of intranasal histamine on nasal mucosal blood flow and the antidiuretic activity of desmopressin.
    Olanoff LS; Titus CR; Shea MS; Gibson RE; Brooks CD
    J Clin Invest; 1987 Sep; 80(3):890-5. PubMed ID: 3624491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and rhinostereometric assessment of nasal mucosal swelling during histamine challenge.
    Graf P; Hallén H
    Clin Otolaryngol Allied Sci; 1996 Feb; 21(1):72-5. PubMed ID: 8674227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new administration form of the nasal decongestant oxymetazoline: a study on the change of ostial patency in healthy individuals.
    Jannert M; Fryksmark U; Ackerhans M; Nilson K
    Rhinology; 1994 Jun; 32(2):78-80. PubMed ID: 7939146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of spontaneous fluctuations in congestion and nasal mucosal microcirculation and the effects of oxymetazoline using rhinostereometry and micromanipulator guided laser Doppler flowmetry.
    Grudemo H; Juto JE
    Am J Rhinol; 1999; 13(1):1-6. PubMed ID: 10088021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Laser Doppler flow signal frequency analysis in physiological and drug modified nasal flow motion].
    Siegert R; Klitzing L
    HNO; 1996 Sep; 44(9):497-502. PubMed ID: 9005230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal airway resistance after decongestion with a nasal spray or a bellows device.
    Jessen M; Ivarsson A; Malm L
    Rhinology; 1996 Mar; 34(1):28-31. PubMed ID: 8739865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superficial nasal mucosal blood flow and nasal patency following topical oxymetazoline hydrochloride.
    Witek TJ; Canestrari DA; Hernandez JR; Miller RD; Yang JY; Riker DK
    Ann Allergy; 1992 Feb; 68(2):165-8. PubMed ID: 1739191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secretoneurin is released into human airways by topical histamine but not capsaicin.
    Korsgren M; Fischer-Colbrie R; Andersson M; Coman WB; Mackay-Sim A; Persson CG; Sundler F; Wallwork B; Greiff L
    Allergy; 2005 Apr; 60(4):459-63. PubMed ID: 15727576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of azelastine nasal spray on histamine-and allergen-induced skin wheal response in patients with allergic rhinitis.
    Agarwal MK; Vijayan VK; Vermani M
    J Asthma; 2008 Sep; 45(7):548-51. PubMed ID: 18773324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits.
    Suh SH; Chon KM; Min YG; Jeong CH; Hong SH
    Acta Otolaryngol; 1995 Sep; 115(5):664-71. PubMed ID: 8928640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.